CORRECTING and REPLACING First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Remove sixth paragraph of release: (Class 1 new drug refers to…